Literature DB >> 29110054

Diffusion-weighted imaging and pathology of chronic kidney disease: initial study.

Xueqin Xu1, Suzanne L Palmer2, Xiaozhu Lin1, Weixia Li1, Kemin Chen1, Fuhua Yan1, Xiao Li3.   

Abstract

PURPOSE: To investigate the value of diffusion-weighted imaging (DWI) for assessing histopathologic changes observed in chronic kidney disease (CKD).
METHODS: Fifty-two patients with CKD underwent DWI before renal biopsy. The renal apparent diffusion coefficient (ADC) values and histopathologic changes were analyzed. The pathologic changes were scored using a semi-quantitative method (no lesion as 0, mild lesion as 1, moderate lesion as 2, and severe lesion as 3). The relationships between renal histopathologic scores, types, classification, and right renal ADCs were analyzed using ANOVA and Pearson's or Spearman's correlation tests.
RESULTS: Negative correlations were found between the right renal ADCs and scores of tubulointerstitial lesions (r = - 0.354, P = 0.012), the severity of tubular atrophy (r = - 0.439, P = 0.002), and the severity of interstitial fibrosis (r = - 0.272, P = 0.049). There were no correlations between the ADCs and scores of glomeruli and peritubular vessel lesions (P > 0.05). There were significant differences among groups based on pathology types (P = 0.009). There was no significant relationship between renal ADCs and the pathologic classification (P > 0.05).
CONCLUSIONS: DWI may be helpful to detect tubulointerstitial injury, including tubular atrophy and interstitial fibrosis. DWI may have the potential to serve as an effective auxiliary method to help nephrologists to evaluate patients with CKD.

Entities:  

Keywords:  Apparent diffusion coefficient; Chronic kidney disease; Diffusion-weighted imaging; Magnetic resonance imaging; Pathologic changes

Mesh:

Year:  2018        PMID: 29110054     DOI: 10.1007/s00261-017-1362-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  7 in total

1.  Relationship of renal apparent diffusion coefficient and functional MR urography in children with pelvicalyceal dilation.

Authors:  Maria A Bedoya; Jeffrey I Berman; Jorge Delgado; Dmitry Khrichenko; Christian A Barrera; Robert H Carson; Kassa Darge
Journal:  Pediatr Radiol       Date:  2019-04-19

Review 2.  Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques.

Authors:  Kai Jiang; Christopher M Ferguson; Lilach O Lerman
Journal:  Transl Res       Date:  2019-04-22       Impact factor: 7.012

3.  Quantitative assessment of renal allograft pathologic changes: comparisons of mono-exponential and bi-exponential models using diffusion-weighted imaging.

Authors:  Min Fan; Zhaoyu Xing; Yanan Du; Liang Pan; Yangyang Sun; Xiaozhou He
Journal:  Quant Imaging Med Surg       Date:  2020-06

4.  Detection of water-molecular-motion configuration in patients with lupus nephritis: a primary study using diffusion-weighted imaging.

Authors:  Huilan Shi; Yanyan Wang; Tiekun Yan; Junya Jia; Dong Li; Li Wei; Wenya Shang; Zhenfeng Zheng
Journal:  BMC Nephrol       Date:  2020-07-29       Impact factor: 2.388

5.  Diffusion Weighted Magnetic Resonance Imaging in the Assessment of Renal Function and Parenchymal Changes in Chronic Kidney Disease: A Preliminary Study.

Authors:  Katarzyna Sułkowska; Piotr Palczewski; Agnieszka Furmańczyk-Zawiska; Agnieszka Perkowska-Ptasińska; Damian Wójcik; Wojciech Szeszkowski; Magdalena Durlik; Marek Gołębiowski; Piotr Małkowski
Journal:  Ann Transplant       Date:  2020-03-03       Impact factor: 1.530

6.  Alterations of Renal Function in Patients with Diabetic Kidney Disease: A BOLD and DTI Study.

Authors:  Xiaobao Wei; Runyue Hu; Xiaoli Zhou; Lihua Ni; Dongqing Zha; Huiling Feng; Haibo Xu; Xiaoyan Wu
Journal:  Comput Intell Neurosci       Date:  2022-09-30

7.  Characteristics of diffusion-weighted and blood oxygen level-dependent magnetic resonance imaging in Tubulointerstitial nephritis: an initial experience.

Authors:  Tao Su; Xuedong Yang; Rui Wang; Li Yang; Xiaoying Wang
Journal:  BMC Nephrol       Date:  2021-06-29       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.